Original article
A comparative cost analysis of terminal cancer care in home hospice patients and controls

https://doi.org/10.1016/0021-9681(87)90132-9Get rights and content

Abstract

A comparison is made between the expenditure during the last 90 days of life on 98 terminal cancer patients cared for by a home based hospice service and that on matched patients dying without the home hospice service. The control patients were matched for site of primary cancer, age and sex. The individual records of both groups of patients were analyzed and costed. It was found that the costs of providing 24 hour comprehensive medical and nursing care at home to those dying of cancer and support for their families was no more expensive than traditional institutional care.

References (13)

There are more references available in the full text version of this article.

Cited by (31)

  • WHO/ISH total risk approach for primary prevention of cardiovascular disease shows greater decrease in costs for women but not the elderly in Jamaica

    2015, Journal of Clinical Epidemiology
    Citation Excerpt :

    The elderly was defined as individuals 60 years of age or older. CA is an economic evaluation method for assessing treatment approaches when different alternatives produce the same outcome [22] or if cost minimization is the objective [23]. CA has been applied to examine differences in costs of care for chronic disease patients by age and health insurance status [24] and cost of drug for alternative approaches to CVD risk treatment [19].

  • Do community specialist palliative care services that provide home nursing increase rates of home death for people with life-limiting illnesses? A systematic review and meta-analysis of comparative studies

    2013, Journal of Pain and Symptom Management
    Citation Excerpt :

    This was followed with the Egger regression method, fitting a linear model of the standardized treatment effect on its precision (i.e., the inverse of the variance).30 Of 1492 articles screened, 10 articles31–40 reporting nine studies and enabling 10 comparisons met eligibility criteria (Fig. 1). Table 2 provides a summary of the nine SPCS home nursing interventions evaluated against key criteria.

  • An estimate of the annual direct cost of treating cutaneous melanoma

    1998, Journal of the American Academy of Dermatology
View all citing articles on Scopus
View full text